Page: Financial advantages of SME status-2025/1/15

Document: Timetable: Initial (full) marketing authorisation application accelerated assessment timetables - Advanced therapy medicinal product (ATMP)-2025/1/14

Document: Timetable: Extension application - ATMP-2025/1/14

Document: Work plan for the Committee for Veterinary Medicinal Products (CVMP) Pharmacovigilance Working Party (PhVWP-V) 2025-2025/1/14

Document: Policy 44: European Medicines Agency policy on the handling of competing interests of scientific committees’ members and experts - As adopted by EMA Management Board on 11-12 December 2024-2025/1/14

Document: Policy 58: European Medicines Agency policy on the handling of competing interests of Management Board members - As adopted by EMA Management Board on 11-12 December 2024-2025/1/14

Document: Minutes - HMA-EMA joint Big Data Steering Group teleconference - 11 December 2024-2025/1/14

Page: Handling competing interests-2025/1/14

Document: Overview of comments received on the draft revision of EMA’s Policy on handling competing interests of scientific committee members and experts-2025/1/14

Document: Outcome of Public consultation on Policy 0044 - Summary of comments and EMA feedback-2025/1/14